EMA/PE/0000232760 - paediatric investigation plan

riliprubart

Key facts

• Active substance:
  riliprubart
• Therapeutic area:
  Immune system disorders
• Decision number:
  EMA/PE/0000232760
• PIP number:
  EMA/PE/0000232760
• Pharmaceutical form(s):
  Solution for injection/infusion
• Condition(s) / indication(s):
  Treatment of rejection of transplanted kidney
• Route(s) of administration:
  Intravenous use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  16/05/2025
• Compliance check done:
  Ne

Decision

EMA/PE/0000232760 : EMA decision of 16 May 2026 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for riliprubart

Adopted Reference Number: EMADOC-1700519818-2107432